title: Extending the quality and safety agenda from parenteral to oral chemotherapy.
authors.affiliation: Princess Margaret Cancer Centre; University of Toronto; and Cancer Care Ontario, Toronto, Ontario, Canada monika.krzyzanowska@uhn.ca.
authors.forename: Monika K
authors.initials: MK
authors.lastname: Krzyzanowska
authors.affiliation: Princess Margaret Cancer Centre; University of Toronto; and Cancer Care Ontario, Toronto, Ontario, Canada.
authors.forename: Melanie
authors.initials: M
authors.lastname: Powis
mesh_terms: D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D011307:Drug Prescriptions / Q000592:standards; D004501:Education, Medical / Q000592:standards; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007263:Infusions, Parenteral; D008495:Medical Oncology / Q000592:standards*; D055118:Medication Adherence; D009369:Neoplasms / Q000188:drug therapy*; D010353:Patient Education as Topic / Q000592:standards; D061214:Patient Safety / Q000592:standards; D010593:Pharmaceutical Services / Q000592:standards; D017064:Process Assessment, Health Care / Q000592:standards*; D058996:Quality Improvement / Q000592:standards*; D019984:Quality Indicators, Health Care / Q000592:standards*; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents